From growth-stage to buyout, leading sponsors rely on CapeStart to deliver AI capability across their portfolios.
The life sciences delivery record behind the value-creation work
Selected client experience across healthcare & life sciences. references available on request.
On most PE-backed life sciences companies, AI sits in the value-creation plan and never reaches production before exit. CapeStart ties it directly to the three things the deal is priced on — top-line growth, margin, and defensibility — and ships capability that shows up in the numbers, not in a pilot deck.
For PortCos carrying a growth mandate, we build AI into the product itself — new data-driven features, faster roadmap velocity, and the kind of differentiation a strategic acquirer pays a premium for.
When the plan calls for margin, we automate the document-heavy, expert-time workflows that quietly cap EBITDA — clinical, regulatory, quality, and claims review — so output rises without adding headcount.
AI is now a diligence question. We deliver auditable, explainable capability a buyer can verify — not slideware — so the AI line in the value-creation plan stands up at exit.
The same productized build serves both sides of the table: an AI workstream operating partners and sponsors can underwrite, and operating leverage the PortCo executive team can run — one repeatable motion across the portfolio.
Not a platform to license or a pilot to run. Two scoped engineering builds, delivered by CapeStart’s team into the PortCo — the mechanism behind the revenue and margin outcomes above.
Document Intelligence
Turn unstructured documents into structured, queryable data.
Life sciences PortCos sit on mountains of unstructured documents: clinical files, regulatory submissions, device documentation, contracts, claims, scientific literature. CapeStart builds a capability that extracts, classifies, and structures that content at scale — roughly 70% already built and reused across clients.
- OCR, NLP and document classification, production standard
- Structured fields extracted from unstructured sources
- Integrated via API into the product or workflow
- Tuned for regulated, high-accuracy life sciences data
On a systematic literature-review build, CapeStart cut review time by 60%, unifying library, medical-writing, and clinical teams on one platform for search, screening, extraction, and report generation.
Conversational Search
Let people ask your data questions in natural language.
People and customers shouldn't need to know where information lives or how to query it. CapeStart builds a natural-language interface over the company's content and data, grounded in its sources — roughly 70% already built and reused across clients — so answers are accurate, cited, and trustworthy enough for a regulated setting.
- RAG-based search grounded in the company's own data
- Cited, source-backed answers that reduce hallucination risk
- Integrated into the product or internal tools via API
- Tuned for the precision life sciences users require
A conversational media-intelligence assistant returned insights in seconds and scaled across millions of documents. Fragmented access became instant, cited answers — driving retention and stickiness.
Advisory shops hand you a deck. Platform vendors hand you a license. Offshore teams hand you capacity. CapeStart is the blend of all three — and that’s the differentiation.
Roughly 70% of each build already exists and is reused across clients — engagements start from a working asset, not a blank page.
60+ AI/ML implementations across life sciences, healthcare, and pharma, with 90%+ proven model accuracy.
HIPAA, SOC 2 Type 2, and GDPR validated in your environment — evidence ready before a buyer’s diligence asks.
From value-creation plan to exit
Proven on your data in 4 weeks
Built compliant for regulated life sciences
60+
AI/ML implementations in life sciences, healthcare & pharma
6 of 15
Top-15 life sciences companies served
90%+
Proven model accuracy on production builds
4 wks
Working prototype that proves value on your data
70%
Of each build already exists as reusable IP
~2 mo
Typical path from prototype to production
LaunchAi won a 2025 Bronze Stevie® Award at the 22nd Annual International Business Awards® for its innovative AI/ML solution supporting life sciences content synthesis.
LaunchAi won a 2026 Artificial Intelligence Excellence Award from the Business Intelligence Group in the Generative AI category.
LaunchAi was included among PM360’s most innovative solutions in 2024.
One four-phase play: prove it on a single portfolio company, then run the same sequence across the rest of the book.
We start from the value-creation plan: where regulated documents and expert time concentrate, and which workflow most directly touches revenue or margin.
Most of the capability is already built. We customize a proven asset to your data and ship a working prototype — more than a demo — that proves measurable value before production spend.
We integrate your data sources, tune for edge cases, and harden the build to HIPAA and SOC 2 Type 2 in your environment — typically a couple of months to production.
The same sequence repeats across the book — lining up the next use case and the next company on a documented play, whatever maturity each PortCo starts from.
Optional : Forward Deployed AI Engineers Embedded with Your PortCo Team
It isn’t about the sub-sector — it’s structural. Two simple tests tell you which build a PortCo needs:
The company holds a large estate of SOPs, protocols, regulatory submissions, validation, or claims documents across PDFs and SharePoint — and an RA, Quality, Medical Affairs, PV, or CMC team that loses hours finding answers in it.
The company’s knowledge is spread across the systems life sciences runs on — Veeva Vault, SharePoint, regulatory and labeling archives, QMS and SOP repositories, Medical Affairs and medical-information libraries, and clinical trial files — with multi-step expert questions answered by hand, and users who want answers where they already work.
— where AI touches revenue or margin in a PortCo, scoped to one priority with clear value logic.
— a four-week prototype proven on the company’s own data before any production spend.
— auditable and compliant, with HIPAA and SOC 2 Type 2 validated in your environment.
— the same documented sequence applied to the next PortCo at any starting maturity.